Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 15/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.49 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20996072 | 1.00 | ABCG2 (0.49) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL21147901 | 0.94 | ABCG2 (0.45) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL25208383 | 0.93 | ABCG2 (0.44) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL30550571 | 0.93 | ABCG2 (0.47) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL25204079 | 0.93 | ABCG2 (0.47) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL30550568 | 0.93 | ABCG2 (0.44) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL29425205 | 0.92 | GABRG2 (0.49) | ABCG2ABCB1MEN1ALDH1A1LMNA | |
| SCHEMBL27008573 | 0.92 | GABRG2 (0.49) | ABCG2ABCB1MEN1ALDH1A1LMNA | |
| SCHEMBL20794068 | 0.91 | ABCG2 (0.47) | ABCG2ABCB1ABCC1MEN1ALDH1A1 | |
| SCHEMBL30550572 | 0.89 | ABCG2 (0.41) | ABCG2ABCB1ABCC1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12250882-B2 | Deuterium-containing compound, and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2025-03-11 | — | — | US | disclosed |
| US-20220271233-A1 | DEUTERIUM-CONTAINING COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-08-25 | — | — | US | disclosed |
| EP-3617290-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |
| WO-2020085842-A1 | DEUTERIUM-CONTAINING COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2020-04-30 | — | — | WO | disclosed |
| EP-3617290-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-03-04 | — | — | EP | disclosed |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| EP-3315581-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-02 | — | — | EP | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
| EP-3315581-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12250882-B2 | Deuterium-containing compound, and organic light-emitting device comprising same | CRY1, CRY2, PER2 | ABCG2 3920/4885ABCB1 4287/4885ABCC1 3972/4885 |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | ABCG2 2585/4885ABCB1 1061/4885ABCC1 1162/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | ABCG2 2585/4885ABCB1 1061/4885ABCC1 1162/4885 |
| US-20220271233-A1 | DEUTERIUM-CONTAINING COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, PER2 | ABCG2 4115/4885ABCB1 4331/4885ABCC1 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.